Name: EVOKE PHARMA INC (EVOK) Stock
Brand: EVOKE PHARMA INC
Rating: 7 (3 reviews)

EVOK Latest News, Press Relases and Analysis

All

Press Releases

7 days ago - By: Chartmill

EVOKE PHARMA INC (NASDAQ:EVOK) Shows Strong Alignment with Minervini Strategy

7 days ago - By: Chartmill - Mentions: RUBI CHAC IHRT PRLD ...

In today's session, these stocks are experiencing unusual volume.

7 days ago - By: Halper Sadeh LLC - Mentions: DENN ODP

Halper Sadeh LLC Encourages DENN, EVOK, ODP Shareholders to Contact the Firm to Discuss Their Rights

7 days ago - By: Brodsky & Smith LLC - Mentions: KVUE SNDA SM KMB ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kenvue Inc. (NYSE - KVUE), Sonida Senior Living, Inc. (NYSE - SNDA), Evoke Pharma Inc. (Nasdaq - EVOK), SM Energy Company (NYSE - SM)

8 days ago - By: Stocktwits - Mentions: GWX SPEU

EVOK Stock Doubled In Value Today Post QOL Medical Deal, But Still Fails To Hit $11 Mark

8 days ago - By: Benzinga - Mentions: DENN NCLH SRPT UBER ...

Gold Falls Over 1%; Uber Shares Decline After Q3 Results

9 days ago - By: Ademi LLP

Shareholder Alert: The Ademi Firm investigates whether Evoke Pharma Inc. is obtaining a Fair Price for its Public Shareholders

9 days ago - By: Benzinga

Evoke Pharma Rockets On Grabbing 140% Premium In Acquisition Deal

9 days ago - By: Halper Sadeh LLC

EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. is Fair to Shareholders

9 days ago - By: Evoke Pharma, Inc.

Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical

3 months ago - By: Evoke Pharma, Inc.

Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship

3 months ago - By: Evoke Pharma, Inc.

Evoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book

3 months ago - By: The Motley Fool

Evoke Pharma Posts 47 Percent Q2 Growth

3 months ago - By: Evoke Pharma, Inc.

Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update

3 months ago - By: Evoke Pharma, Inc.

Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI With Extended Exclusivity to Late 2038

4 months ago - By: Stocktwits

Evoke Pharma Stock Skyrockets On Patent For Nasal Spray That Eases Stomach Delays; Retail Bulls Pile In

4 months ago - By: Evoke Pharma, Inc.

Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036

6 months ago - By: Evoke Pharma, Inc.

Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update

7 months ago - By: Evoke Pharma, Inc.

Evoke Pharma to Present New Data Comparing Tardive Dyskinesia Incidence in Continuous vs Intermittent Metoclopramide Use at DDW 2025

8 months ago - By: Evoke Pharma, Inc.

EVOKE PHARMA INC (EVOK) Stock News

EVOK Latest News, Press Relases and Analysis

EVOKE PHARMA INC (NASDAQ:EVOK) Shows Strong Alignment with Minervini Strategy

In today's session, these stocks are experiencing unusual volume.

Halper Sadeh LLC Encourages DENN, EVOK, ODP Shareholders to Contact the Firm to Discuss Their Rights

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kenvue Inc. (NYSE - KVUE), Sonida Senior Living, Inc. (NYSE - SNDA), Evoke Pharma Inc. (Nasdaq - EVOK), SM Energy Company (NYSE - SM)

EVOK Stock Doubled In Value Today Post QOL Medical Deal, But Still Fails To Hit $11 Mark

Gold Falls Over 1%; Uber Shares Decline After Q3 Results

Shareholder Alert: The Ademi Firm investigates whether Evoke Pharma Inc. is obtaining a Fair Price for its Public Shareholders

Evoke Pharma Rockets On Grabbing 140% Premium In Acquisition Deal

EVOK Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Evoke Pharma, Inc. is Fair to Shareholders

Evoke Pharma Enters into Definitive Agreement to Be Acquired by QOL Medical

Evoke Pharma and EVERSANA Expand GIMOTI® Access to Gastro Health and Other Large GI Practices through Omnicell Relationship

Evoke Pharma Announces Listing of New GIMOTI® Patent in FDA Orange Book

Evoke Pharma Posts 47 Percent Q2 Growth

Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update

Evoke Pharma Announces Issuance of New U.S. Patent for GIMOTI With Extended Exclusivity to Late 2038

Evoke Pharma Stock Skyrockets On Patent For Nasal Spray That Eases Stomach Delays; Retail Bulls Pile In

Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036

Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update

Evoke Pharma to Present New Data Comparing Tardive Dyskinesia Incidence in Continuous vs Intermittent Metoclopramide Use at DDW 2025

Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update